<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02893748</url>
  </required_header>
  <id_info>
    <org_study_id>HGP-0004</org_study_id>
    <nct_id>NCT02893748</nct_id>
  </id_info>
  <brief_title>HyGIeaCare Prep vs Split-dose PEG Prep Prior to Colonoscopy</brief_title>
  <official_title>HyGIeaCare Prep vs Split-dose PEG Prep Prior to Colonoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HyGIeaCare, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>HyGIeaCare, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the level of cleanliness using the HyGIeaCare Prep vs
      the standard of care Split-dose PEG prep used prior to colonoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The level of cleanliness will be recorded using the Boston Bowel Prep Score (BBPS) by an
      endoscopist who is blind to the randomized preparation.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Colon cleanliness will be measured in both groups according to the Boston Bowel Preparation Scale (BBPS)</measure>
    <time_frame>Day 1 of colonoscopy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of patient satisfaction using a Questionnaire</measure>
    <time_frame>2 Days after colonoscopy</time_frame>
    <description>Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of adverse events</measure>
    <time_frame>2 Days after colonoscopy</time_frame>
    <description>Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Colonoscopy</condition>
  <arm_group>
    <arm_group_label>1: HyGIeaCare Prep and Colonoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive:
HyGIeaCare Prep
Colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2: Split-dose PEG Prep and Colonoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive:
Split-dose PEG
Colonoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HyGIeaCare Prep</intervention_name>
    <description>Patients will receive the HyGIeaCare Prep, which is an open colon lavage system using warm water by gravity drip to evacuate the colon by stimulating peristalsis to cleanse the colon prior to colonoscopy.</description>
    <arm_group_label>1: HyGIeaCare Prep and Colonoscopy</arm_group_label>
    <other_name>colon lavage</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Colonoscopy</intervention_name>
    <description>Screening colonoscopy as per standard of care.</description>
    <arm_group_label>1: HyGIeaCare Prep and Colonoscopy</arm_group_label>
    <arm_group_label>2: Split-dose PEG Prep and Colonoscopy</arm_group_label>
    <other_name>Screening Colonoscopy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>polyethylene glycol (PEG)</intervention_name>
    <description>PEG preparation to be delivered in two doses - 1/2 the night before and 1/2 the morning of the colonoscopy</description>
    <arm_group_label>2: Split-dose PEG Prep and Colonoscopy</arm_group_label>
    <other_name>Split-dose PEG Prep</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient referred to colonoscopy

          2. Patient with high probability for poor prep due to one or more of the following:

               1. Chronic constipation (Rome III functional constipation criteria)

               2. Gastroparesis

               3. Immobilization

               4. Diabetes

               5. History of poor prep

        Exclusion Criteria:

          1. Patient has any condition that, in the opinion of the investigator, may adversely
             affect the compliance or safety of the patient or would limit the patient's ability to
             complete the study.

          2. Patient is currently taking narcotics.

          3. Patient has any of the contraindications listed below:

               1. Cardiac: Congestive heart failure (NYHA class III or IV or EF &lt; 50%)

               2. GI: Intestinal perforation, carcinoma of the rectum, fissures or fistula, severe
                  hemorrhoids, abdominal hernia, recent colon or rectal surgery, or abdominal
                  surgery

               3. GU: Renal insufficiency (CC &lt; 60 ml/min/173m2), cirrhosis with ascites

               4. Abdominal surgery within the last 6 months

               5. Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Umar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Research Coordinator</last_name>
    <phone>800-446-2279</phone>
    <email>x@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Central Backup</last_name>
    <phone>800-446-2279</phone>
    <email>x@mayo.edu</email>
  </overall_contact_backup>
  <reference>
    <citation>Johnson DA, Barkun AN, Cohen LB, Dominitz JA, Kaltenbach T, Martel M, Robertson DJ, Boland CR, Giardello FM, Lieberman DA, Levin TR, Rex DK; US Multi-Society Task Force on Colorectal Cancer. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US multi-society task force on colorectal cancer. Gastroenterology. 2014 Oct;147(4):903-24. doi: 10.1053/j.gastro.2014.07.002. Review.</citation>
    <PMID>25239068</PMID>
  </reference>
  <reference>
    <citation>Gagneja HK, Parekh P, Burleson D, Johnson D. HyGIeaCareÂ® Preparation for Colonoscopy - A Technical Update for Success. J Gastrointest Dig Syst 2016; 6: 458. doi:10.4172/2161-069X.1000458</citation>
  </reference>
  <reference>
    <citation>Clark BT, Protiva P, Nagar A, Imaeda A, Ciarleglio MM, Deng Y, Laine L. Quantification of Adequate Bowel Preparation for Screening or Surveillance Colonoscopy in Men. Gastroenterology. 2016 Feb;150(2):396-405; quiz e14-5. doi: 10.1053/j.gastro.2015.09.041. Epub 2015 Oct 9.</citation>
    <PMID>26439436</PMID>
  </reference>
  <reference>
    <citation>Fiorito J, Culpepper-Morgan JA, Estabrook SG, Scofield P, Usatii V, Cuomo R. Hydrotherapy Compared with PEG-ES Lavage and Aqueous Sodium Phosphate as Bowel Preparation for Elective Colonoscopy: A Prospective, Randomized, Single Blinded Trial. ACG Abstract 2006; 751814.</citation>
  </reference>
  <reference>
    <citation>Sportes A, Delvaux M, Huppertz J, Hernandez C, Gay G. Randomized Trial Comparing High Volume Rectal Water Irrigation with Standard 4L Split-dose PEG Preparation Before Colonoscopy. Accepted by Gastroenterology and Digestive Diseases (awaiting publication).</citation>
  </reference>
  <reference>
    <citation>ASGE Standards of Practice Committee, Saltzman JR, Cash BD, Pasha SF, Early DS, Muthusamy VR, Khashab MA, Chathadi KV, Fanelli RD, Chandrasekhara V, Lightdale JR, Fonkalsrud L, Shergill AK, Hwang JH, Decker GA, Jue TL, Sharaf R, Fisher DA, Evans JA, Foley K, Shaukat A, Eloubeidi MA, Faulx AL, Wang A, Acosta RD. Bowel preparation before colonoscopy. Gastrointest Endosc. 2015 Apr;81(4):781-94. doi: 10.1016/j.gie.2014.09.048. Epub 2015 Jan 14.</citation>
    <PMID>25595062</PMID>
  </reference>
  <reference>
    <citation>US Department of Health and Human Services. Common Terminology Criteria for Adverse Events 2009.</citation>
  </reference>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 24, 2016</study_first_submitted>
  <study_first_submitted_qc>September 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2016</study_first_posted>
  <last_update_submitted>September 7, 2016</last_update_submitted>
  <last_update_submitted_qc>September 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>colon</keyword>
  <keyword>polyps</keyword>
  <keyword>cancer</keyword>
  <keyword>screening</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

